| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/11/2007 | EP1806150A1 Teicoplanin composition |
| 07/11/2007 | EP1806147A1 Use of immunesuppressant receptor |
| 07/11/2007 | EP1806146A1 Agonists or antagonists of cutaneous T cell-attracting chemokine (CTACK) or vasoactive intestinal contractor (VIC) chemokines |
| 07/11/2007 | EP1805196A1 Substituted adenines and the use thereof |
| 07/11/2007 | EP1805187A1 Inhibitors of hepatitis c virus protease, and compositions and treatments using the same |
| 07/11/2007 | EP1805172A1 4-methoxymethyl-pyrrolidine-2-carboxylic acid compounds and derivatives thereof as hepatitis c virus inhibitors |
| 07/11/2007 | EP1805134A2 4-aminotetracyclines and methods of use thereof |
| 07/11/2007 | EP1804838A2 Drug conjugates of long chain fatty acid or ester moieties as protein binding prodrugs |
| 07/11/2007 | EP1804812A2 Fluorinated pyrroloý2,3-d¨pyrimidine nucleosides for the treatment of rna-dependent rna viral infection |
| 07/11/2007 | EP1804811A2 Methods and compositions for treating flaviviruses, pestiviruses and hepacivirus |
| 07/11/2007 | EP1660495B1 Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate |
| 07/11/2007 | EP1639029B1 Biodegradable poly(beta-amino esters) and uses thereof |
| 07/11/2007 | EP1535065A4 Neuroprotective synergy of erythropoietin and insulin-like growth factor |
| 07/11/2007 | EP1461361B1 Negatively charged polysaccharide derivable from aloe vera |
| 07/11/2007 | EP1420822B1 Modified vaccinia virus ankara for the vaccination of neonates |
| 07/11/2007 | EP1366021B1 Substituted diarylureas as stimulators for fas-mediated apoptosis |
| 07/11/2007 | EP1357917B1 Use of carbohydrates for eliminating intestinal infections in animals |
| 07/11/2007 | EP1307198A4 Protoberberine derivatives which inhibit activity of the mitogen-activated protein kinase |
| 07/11/2007 | EP1303265B1 Use of cox-2 inhibitors as immunostimulants in the treatment of hiv or aids |
| 07/11/2007 | EP1171576B1 Pseudomycin production by pseudomonas syringae |
| 07/11/2007 | EP1146889B1 IDENTIFICATION OF SPECIFIC DIFFERENTIALLY EXPRESSED MYCOBACTERIAL ANTIGENS AND MEDICAL USE OF THE MYCOBACTERIAL PROTEINS Rv0068 AND Rv3407 |
| 07/11/2007 | EP1105467B1 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES |
| 07/11/2007 | EP1071767B1 Gene coding for heliomicine and use thereof |
| 07/11/2007 | EP1037917B1 Recombinant nodavirus compositions and methods |
| 07/11/2007 | EP1028945B1 Substituted pyridine compounds as anti-inflammatory agents |
| 07/11/2007 | CN1997662A Inhibitors based on fusion, HR1 and HR2 sequences in bacterial adhesin |
| 07/11/2007 | CN1997642A 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 07/11/2007 | CN1997392A Neisseria meningitidis igtB LOS as adjuvant |
| 07/11/2007 | CN1997366A Imidazole and thiazole derivatives as antiviral agents |
| 07/11/2007 | CN1995354A Mycobacterium tuberculosis succinyl coenzymea A synthase gene and its uses |
| 07/11/2007 | CN1995352A Mycobacterium tuberculosis cold-shock protein and its uses |
| 07/11/2007 | CN1995345A Recombinant L-251 protein with anti-inflammatory effect secreted by Japanese lamprey oral gland |
| 07/11/2007 | CN1995340A Mycobacterium tuberculosis glucosamine-6-phosphate synthase gene and its uses |
| 07/11/2007 | CN1995335A Tubercle bacillus rhodanase and its uses |
| 07/11/2007 | CN1995056A Curcumenol glucoside compound and its preparation method and uses |
| 07/11/2007 | CN1995042A Substituted 1,2,3- triazolepyridine compound with HIV-resistant activity, preparation method and uses |
| 07/11/2007 | CN1995036A Optical purity alpha-substituted 2-methyl-5-nitro imidazole-1-ethanol derivative |
| 07/11/2007 | CN1994470A Genetic engineering polypeptide vaccine adjuvant for aftosa, preparation method and application thereof |
| 07/11/2007 | CN1994466A Use of composition for treatment of viral infections |
| 07/11/2007 | CN1994465A CCR5 autogenous polypeptide vaccine and preparation method thereof |
| 07/11/2007 | CN1994454A Orally administered Chinese medicine for treating viral myocarditis caused by phlegm fire disturbing heart |
| 07/11/2007 | CN1994438A Orally administered Chinese medicine for treating acute bronchitis accompanied with throat itching |
| 07/11/2007 | CN1994437A Orally administered Chinese medicine for treating cold |
| 07/11/2007 | CN1994435A Chinese herbal tea preparation for treating acute viral myocarditis |
| 07/11/2007 | CN1994425A Soft capsule of 'Sheng Mai' and preparation method thereof |
| 07/11/2007 | CN1994378A Compound formulation for treating icteric viral hepatitis and method for preparing same |
| 07/11/2007 | CN1994374A Preparation method of papermulberry extract and use thereof |
| 07/11/2007 | CN1994364A Subprostrate soplhor root extract refining process |
| 07/11/2007 | CN1994356A Externally applied medicine for treating herpes zoster |
| 07/11/2007 | CN1994352A Use of total glucosides extract of cocklebur fruit in preparation of product for resisting inflammatory reaction |
| 07/11/2007 | CN1994341A Preparation process of total phenolic acids of water cress and pharmaceutical formulation using the ingredient as bulk drug and use thereof for treating liver disease |
| 07/11/2007 | CN1994336A Use of basket fern polysaccharides in preparation of medicament for preventing and treating acute respiratory distress syndrome |
| 07/11/2007 | CN1994301A Heterocyclic compounds which are active as inhibitors of beta lactamases |
| 07/11/2007 | CN1994299A Use of medicine for treating virus infection of respiratory system |
| 07/11/2007 | CN1994298A Carbamate aspartic acid specific cysteine proteinase inhibitors and uses thereof |
| 07/11/2007 | CN1994295A Enteric-coated pharmaceutical composition of mycophenolic acid salt |
| 07/11/2007 | CN1994294A Use of plant extract catechin in preparation of antivirus medicine |
| 07/11/2007 | CN1994278A Sustained-release preparation using acetaminopher, desloratadine and pseudo ephedrine sulfat as active ingredients and preparation process thereof |
| 07/11/2007 | CN1325656C Vancoresmycin, a process for its production and its use as a pharmaceutical |
| 07/11/2007 | CN1325517C Anti hepatitis C virus antibody and uses thereof |
| 07/11/2007 | CN1325515C Scylla serrata antibacterial peptide and its genes and clone method for genes |
| 07/11/2007 | CN1325512C Fusion protein of HIV regulatory/accessory proteins |
| 07/11/2007 | CN1325497C Pharmaceutically active isoindoline derivs. |
| 07/11/2007 | CN1325493C Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist |
| 07/11/2007 | CN1325488C Heterocyclic derivatives |
| 07/11/2007 | CN1325475C Quinoline derivatives and their use as mycobacterial inhibitors |
| 07/11/2007 | CN1325117C 联合疫苗组合物 Combined vaccine composition |
| 07/11/2007 | CN1325111C Traditional Chinese medicine composition for treating colpitis and cervicitis, prepn. method and quality standard therefor |
| 07/11/2007 | CN1325108C Lesser galangal extract and its use |
| 07/11/2007 | CN1325095C Health caring beer with cold preventing and treating function |
| 07/11/2007 | CN1325091C Parotitis treating medicine |
| 07/11/2007 | CN1325079C Chinese medicine picrorhiza extract possessing anti hepatitis B virus activity and its preparation method |
| 07/11/2007 | CN1325067C Liver disease treating preparation and preparing method and purpose |
| 07/11/2007 | CN1325065C Composition for improving intestine and gastric action |
| 07/11/2007 | CN1325049C Composition containing epigallocatechin gallate |
| 07/11/2007 | CN1325048C Application of wogonin for preparing medicine to treat or prevent hepatitis B |
| 07/11/2007 | CN1325046C Biodegradable polymeric nanocapsules and uses thereof |
| 07/11/2007 | CN1324965C Disinfecting composition based on H2O2 acids and metal ions |
| 07/10/2007 | US7241921 hydroxamic acid and N-formyl hydroxylamine compounds which inhibit the activity of the bacterial enzyme known as peptide deformylase |
| 07/10/2007 | US7241892 Hemisynthetic method and new compounds |
| 07/10/2007 | US7241890 Heat shock protein 90 inhibitors; breast cancer, melanomas; inflammation, infectious diseases, autoimmune disorders, ischemia |
| 07/10/2007 | US7241882 Polyamide nucleic acid derivatives, and agents, and processes for preparing them |
| 07/10/2007 | US7241796 Peptidomimetic compounds |
| 07/10/2007 | US7241795 2,5-bis ((alkyl (or aryl) imino) aminophenyl) furans, thiophenes or pyrroles; Mycobacterium tuberculosis, Trypanosoma spp., Candida albicans, Aspergillus spp., Cryptosporidium parvum, Giardia lamblia, Plasmodium spp., Pneumocystis carinii, Toxoplasma gondii, Fusarium solani, and Cryptococcus neoformans |
| 07/10/2007 | US7241794 Nonnucleoside reverse transcriptase inhibitors |
| 07/10/2007 | US7241777 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors |
| 07/10/2007 | US7241741 Respiratory system disorders ; concurrent administering fungicides, bactericides |
| 07/10/2007 | US7241738 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/10/2007 | US7241733 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 07/10/2007 | US7241618 A polynucleotide comprising a RNA polymerase promoter, able encoding a siRNA; treating cancer and genetic disorders; genetic engineering, inhibit gene expression of a target gene |
| 07/10/2007 | US7241592 Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use |
| 07/10/2007 | US7241576 Applications of a novel cytokine, named THANK, for TNF homologue that activates apoptosis, NF- kappa B and c-jun N-terminal kinase. Such applications include using THANK inhibitors to inhibit the activation of NF-kappa B and to |
| 07/10/2007 | US7241458 Antiviral compositions |
| 07/10/2007 | US7241445 Human monoclonal antibody against hepatitis C virus E2 glycoprotein |
| 07/10/2007 | CA2466340C Farnesyl dibenzodiazepinone, processes for its production and its use as a pharmaceutical |
| 07/10/2007 | CA2370686C Implant for recreating verterbrae and tubular bones |
| 07/10/2007 | CA2366072C Prrsv vaccines |
| 07/10/2007 | CA2200991C Compounds for the suppression of hiv tat transactivation |
| 07/10/2007 | CA2124769C Recombinant foamy virus vectors for medicinal and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 07/10/2007 | CA2121324C Cephalosporin derivatives |